In the presence of former UN-Secretary-General Kofi Annan and Dutch minister Melanie Schultz of Infrastructure & the Environment, Micreos' alternative to antibiotics was chosen as the most impactful innovation of The Netherlands
Micreos will represent The Netherlands at the semi-finals of Ideas from Europe in Talinn, Estonia on 22 November 2017.
Micreos' endolysin technology, enabling targeted killing of only unwanted bacteria — regardless of antibiotic resistance — was selected by a professional jury.
Jury-chair Kasja Ollongren, Deputy Mayor of Amsterdam, emphasised the impact Micreos' products can have for millions of people.
The Making Waves-conference was attended by hundreds of policy makers, entrepreneurs, investors and developers.
Guest of honour, Kofi Annan, winner of the Nobel Peace Prize, said: “I am really excited about Micreos' alternative to antibiotics.”
Kasja Ollongren: “We chose Micreos because the company's technology is already helping tens of thousands of people and we are convinced Micreos' alternative to antibiotics can be life-changing for millions.”
Micreos CEO Mark Offerhaus: “Antibiotic-resistance is an enormous global problem. We are honoured with the recognition. Gladskin has already been life-changing for people suffering from inflammatory skin diseases such as eczema, acne, rosacea and wound infections caused or aggravated by the Staphylococcus aureus bacteria, including the resistant MRSA.”
“But as far as we are concerned, this only marks the beginning. Our endolysin technology offers a real and sustainable alternative to antibiotics, the broad potential of this technology is immeasurable. There is no need to wait and no time to lose.”